<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="3515">
  <stage>Registered</stage>
  <submitdate>4/04/2012</submitdate>
  <approvaldate>4/04/2012</approvaldate>
  <nctid>NCT01576016</nctid>
  <trial_identification>
    <studytitle>Safety and Efficacy of the Accent Magnetic Resonance Imaging (MRI) Pacemaker and Tendril MRI Lead</studytitle>
    <scientifictitle>Accent Magnetic Resonance Imaging Pacemaker and Tendril Magnetic Resonance Imaging Lead Investigational Device Exemption Study</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>60028820</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Adverse Effect of MRI on an Implanted Pacemaker Lead</healthcondition>
    <healthcondition>Adverse Effect of MRI on an Implanted Pacemaker</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: devices - Accent MRI system
Treatment: devices - Accent MRI system

Active Comparator: Accent MRI system MRI Scan Group - Patient implanted with an Accent MRI system will receive an MRI scan

Placebo Comparator: Accent MRI System MRI Control Group - Patient implanted with an Accent MRI system will not receive an MRI scan


Treatment: devices: Accent MRI system
Patients implanted with an Accent MRI system will receive 30 minutes of magnetic scan imaging

Treatment: devices: Accent MRI system
Patients implanted with an Accent MRI system will wait for one hour without receiving an MRI scan

</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Freedom from right atrial (RA) lead-related complications in the acute period - Proportion of patients who do not have RA lead-related complications from implant through the 2 month study visit</outcome>
      <timepoint>Implant through 2 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Freedom from right ventricular (RV) lead-related complications in the acute time period - Proportion of patients who do not have RV lead-related complications from implant through the 2 month study visit</outcome>
      <timepoint>Implant through 2 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Freedom from RA related complications in the chronic period - Proportion of patients who do not have RA lead-related complications from the 2 month through the 12 month study visit</outcome>
      <timepoint>2 months thru 12 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Freedom from right ventricular lead related complications in the chronic period - Proportion of patients who do not have RV lead-related complications from the 2 month through the 12 month study visit</outcome>
      <timepoint>2 months thru 12 months</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Freedom from MRI scan-related complications - Proportion of patients who do not have MRI-related complications from the MRI scan visit to the 1 month post MRI scan visit</outcome>
      <timepoint>MRI Scan visit and 1 month after MRI scan visit</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in atrial capture thresholds (before and after the MRI Scan) - Difference in the proportion of patients with an increase in RA capture thresholds at 0.5 ms between those randomized to receive an MRI scan versus those not receiving an MRI scan.</outcome>
      <timepoint>MRI Scan visit and 1 month after MRI scan visit</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in ventricular capture thresholds (before and after the MRI scan) - Difference in the proportion of patients with an increase in RV capture thresholds at 0.5 ms between those randomized to receive an MRI scan versus those not receiving an MRI scan.</outcome>
      <timepoint>MRI Scan visit and 1 month after MRI scan visit</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in atrial sensing threshold (before and after the MRI scan) - Difference in the proportion of patients with an increase in RA sensing threshold between those randomized to receive an MRI scan versus those not receiving an MRI scan.</outcome>
      <timepoint>MRI Scan visit and 1 month after MRI scan visit</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in ventricular sensing threshold (before and after the MRI scan) - Difference in the proportion of patients with an increase in RV sensing threshold between those randomized to receive an MRI scan versus those not receiving an MRI scan.</outcome>
      <timepoint>MRI Scan visit and 1 month after the MRI Scan visit</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Freedom from system-related complications - Proportion of patients who do not have system-related complications from implant through the 12 month study visit</outcome>
      <timepoint>Implant through 12 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Atrial capture threshold at the MRI visit - Proportion of patients with RA capture threshold =2.0 volts (V) at the MRI visit</outcome>
      <timepoint>MRI Scan visit (approx 3 months post implant)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Ventricular capture threshold at the MRI visit - Proportion of patients with RV capture threshold =2.0 V at the MRI visit</outcome>
      <timepoint>MRI Scan visit (approx 3 months post implant)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Eligible patients will meet all of the following:

          1. Have an approved indication per American College of Cardiology (ACC)/American Heart
             Association (AHA)/Heart Rhythm Society (HRS) guidelines for implantation of a
             pacemaker

          2. Will receive a new pacemaker and lead

          3. Be willing to undergo an elective MRI scan without sedation

          4. Be able to provide informed consent for study participation (legal guardian is NOT
             acceptable)

          5. Be willing and able to comply with the prescribed follow-up tests and schedule of
             evaluations

          6. Is not contraindicated for an MRI scan (per the pre-MRI safety screening form)</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients will be excluded if they meet any of the following:

          1. Are medically indicated for an MRI scan at the time of enrollment

          2. Have an existing pacemaker or implantable cardioverter defibrillator (ICD). A new
             pacemaker and lead is required for enrollment

          3. Have an existing active/inactive implanted medical device, e.g., neurostimulator,
             infusion pump, etc.

          4. Have a non-MRI compatible device or material implanted (e.g., intracranial aneurysm
             clip, non-MRI compatible devices or material, metals or alloys, etc.)

          5. Have a lead extender or adaptor

          6. Be unable to fit in MRI bore; will come into contact with the magnet fa√ßade inside the
             MRI bore.

          7. Have a prosthetic tricuspid heart valve

          8. Are currently participating in a clinical investigation that includes an active
             treatment arm

          9. Are allergic to dexamethasone sodium phosphate (DSP)

         10. Are pregnant or planning to become pregnant during the duration of the study

         11. Have a life expectancy of less than 12 months due to any condition

         12. Patients with exclusion criteria required by local law (e.g., age)

         13. Are unable to comply with the follow up schedule</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/03/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>800</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>1/12/2017</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
    <hospital>St. Andrews Hospital - Adelaide</hospital>
    <postcode>5000 - Adelaide</postcode>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Alabama</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Arizona</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Arkansas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>California</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Colorado</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Florida</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Georgia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Illinois</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Kentucky</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Louisiana</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Michigan</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Minnesota</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Missouri</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Nebraska</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>New York</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>North Carolina</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Ohio</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Oklahoma</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Pennsylvania</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>South Carolina</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Texas</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Virginia</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Washington</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>United States</country>
      <state>Wisconsin</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Belgium</country>
      <state>B Cap R</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Finland</country>
      <state>East Finland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Netherlands</country>
      <state>Utrecht</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>St. Jude Medical</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The MRI Study is a prospective, multi-center, clinical study designed to evaluate the safety
      and efficacy of the Accent MRI System in a patient population indicated for implant of a
      pacemaker within and outside of the MRI environment.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT01576016</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Grant Kim</name>
      <address>St. Jude Medical</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>